Carl Nathan, MD
Carl Nathan, MD is a Scientific Advisor to Ipinovyx Bio and is the R.A. Rees Pritchett Professor and chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine.
After Graduation from Harvard College and Harvard Medical School, he trained in internal medicine and oncology at Massachusetts General Hospital, the National Cancer Institute and Yale before joining the faculty of The Rockefeller University from 1977-1986. At Cornell since 1986, he has served as Stanton Griffis Distinguished Professor of Medicine, founding director of the Tri-Institutional MD-PhD Program, senior associate dean for research, and acting dean.
Nathan is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, a Fellow if the American Academy of Microbiology, associate scientific director of the Cancer Research Institute, a governor of the Tres Cantos Open Lab Foundation, a member of the Board of Directors of the Tri-Institutional Therapeutics Discovery Institute, on the scientific advisory boards of the American Asthma Foundation, and the Rita Allen Foundation, and on the jury of the Lurie Prize. He served for ten years on the SAB of the Cambridge Instute for the Medical Research and the Board of Trustees of the Hospital for Special Surgery. He has been and editor of the Journal of Experimental Medicine since 1981 and joined the editorial board of the Proceeding of the National Academy of Sciences in 2014. He was awarded the Robert Koch Prize in 2009 for his work on tuberculosis and the Anthony Cerami Award in Translational Medicine in 2013.